Causes and Pathogenesis of Focal Segmental Glomerulosclerosis

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2014 Dec 3

PMID 25447132

Citations 148

Authors

Agnes B Fogo

Affiliations

Soon will be listed here.

Abstract

Focal segmental glomerulosclerosis (FSGS) describes both a common lesion in progressive kidney disease, and a disease characterized by marked proteinuria and podocyte injury. The initial injuries vary widely. Monogenetic forms of FSGS are largely due to alterations in structural genes of the podocyte, many of which result in early onset of disease. Genetic risk alleles in apolipoprotein L1 are especially prevalent in African Americans, and are linked not only to adult-onset FSGS but also to progression of some other kidney diseases. The recurrence of FSGS in some transplant recipients whose end-stage renal disease was caused by FSGS points to circulating factors in disease pathogenesis, which remain incompletely understood. In addition, infection, drug use, and secondary maladaptive responses after loss of nephrons from any cause may also cause FSGS. Varying phenotypes of the sclerosis are also manifest, with varying prognosis. The so-called tip lesion has the best prognosis, whereas the collapsing type of FSGS has the worst prognosis. New insights into glomerular cell injury response and repair may pave the way for possible therapeutic strategies.

Citing Articles

Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study.

Richfield O, Cortez R, Kulthinee S, Franco M, Navar L Int J Mol Sci. 2025; 26(5).

PMID: 40076554 PMC: 11900630. DOI: 10.3390/ijms26051928.

Development of a Diagnostic Model for Focal Segmental Glomerulosclerosis: Integrating Machine Learning on Activated Pathways and Clinical Validation.

Ge Y, Liu X, Shu J, Jiang X, Wu Y Int J Gen Med. 2025; 18:1127-1142.

PMID: 40026806 PMC: 11872063. DOI: 10.2147/IJGM.S498407.

The role of endothelin receptor antagonists in kidney disease.

Ma X, Liang Y, Chen W, Zheng L, Lin H, Zhou T Ren Fail. 2025; 47(1):2465810.

PMID: 40015728 PMC: 11869344. DOI: 10.1080/0886022X.2025.2465810.

Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury.

Zhu Y, Xu G Drug Des Devel Ther. 2025; 19:857-875.

PMID: 39935575 PMC: 11812565. DOI: 10.2147/DDDT.S498457.

Functional analysis of heterozygous variants in the SALL1 gene in 2 children with Townes-Brocks syndrome with FSGS.

Liang R, Zheng B, Wang C, Zhao S, Zhou W, Chen Y BMC Pediatr. 2025; 25(1):99.

PMID: 39910415 PMC: 11796162. DOI: 10.1186/s12887-024-05326-5.

References

Sugimoto H, Mundel T, Sund M, Xie L, Cosgrove D, Kalluri R . Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A. 2006; 103(19):7321-6. PMC: 1464339. DOI: 10.1073/pnas.0601436103. View

Collins A, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A . US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2010; 57(1 Suppl 1):A8, e1-526. DOI: 10.1053/j.ajkd.2010.10.007. View

Meyer-Schwesinger C, Lange C, Brocker V, Agustian P, Lehmann U, Raabe A . Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol. 2011; 178(2):494-9. PMC: 3069901. DOI: 10.1016/j.ajpath.2010.10.024. View

Laouari D, Burtin M, Phelep A, Martino C, Pillebout E, Montagutelli X . TGF-alpha mediates genetic susceptibility to chronic kidney disease. J Am Soc Nephrol. 2010; 22(2):327-35. PMC: 3029905. DOI: 10.1681/ASN.2010040356. View

Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo A, Ichikawa I . Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol. 2010; 300(3):F792-800. PMC: 3064125. DOI: 10.1152/ajprenal.00570.2010. View

Medapalli R, He J, Klotman P . HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens. 2011; 20(3):306-11. PMC: 3153858. DOI: 10.1097/MNH.0b013e328345359a. View

Narita M, Young A, Arakawa S, Samarajiwa S, Nakashima T, Yoshida S . Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science. 2011; 332(6032):966-70. PMC: 3426290. DOI: 10.1126/science.1205407. View

Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S . Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011; 121(6):2197-209. PMC: 3104746. DOI: 10.1172/JCI44774. View

Fogo A . The targeted podocyte. J Clin Invest. 2011; 121(6):2142-5. PMC: 3104780. DOI: 10.1172/JCI57935. View

10.

Smeets B, Kuppe C, Sicking E, Fuss A, Jirak P, van Kuppevelt T . Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011; 22(7):1262-74. PMC: 3137574. DOI: 10.1681/ASN.2010090970. View

11.

Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo A . Podocyte injury damages other podocytes. J Am Soc Nephrol. 2011; 22(7):1275-85. PMC: 3137575. DOI: 10.1681/ASN.2010090963. View

12.

Bertram J, Douglas-Denton R, Diouf B, Hughson M, Hoy W . Human nephron number: implications for health and disease. Pediatr Nephrol. 2011; 26(9):1529-33. DOI: 10.1007/s00467-011-1843-8. View

13.

Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J . Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011; 17(8):952-60. PMC: 4089394. DOI: 10.1038/nm.2411. View

14.

Kopp J, Nelson G, Sampath K, Johnson R, Genovese G, An P . APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011; 22(11):2129-37. PMC: 3231787. DOI: 10.1681/ASN.2011040388. View

15.

DAgati V, Kaskel F, Falk R . Focal segmental glomerulosclerosis. N Engl J Med. 2011; 365(25):2398-411. DOI: 10.1056/NEJMra1106556. View

16.

Shkreli M, Sarin K, Pech M, Papeta N, Chang W, Brockman S . Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med. 2011; 18(1):111-9. PMC: 3272332. DOI: 10.1038/nm.2550. View

17.

Zhang J, Hansen K, Pippin J, Chang A, Taniguchi Y, Krofft R . De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy. Am J Physiol Renal Physiol. 2011; 302(5):F571-80. PMC: 3353646. DOI: 10.1152/ajprenal.00516.2011. View

18.

Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A . Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med. 2012; 366(17):1648-9. DOI: 10.1056/NEJMc1202500. View

19.

Zhong J, Zuo Y, Ma J, Fogo A, Jolicoeur P, Ichikawa I . Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 2005; 68(3):1048-60. DOI: 10.1111/j.1523-1755.2005.00497.x. View

20.

Xu B, Shyr Y, Liang X, Ma L, Donnert E, Roberts J . Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol. 2005; 16(10):2967-75. DOI: 10.1681/ASN.2005030262. View